Astellas Pharma, Inc.(ALPMF)- OTCPK - Current
  • Clinically Sound Investor | Send Message 21 Jan 2015

    Astellas' Isavuconazonium Should Pass Ad Comm Meeting For Two Indications $ALPMF http://seekingalpha.com/a/1osbw
    Reply